Anti–IL-23 treatment with tildrakizumab can be effective in omalizumab-refractory chronic spontaneous urticaria: A case series
-
Published:2023-08
Issue:8
Volume:11
Page:2578-2580.e1
-
ISSN:2213-2198
-
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
-
language:en
-
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice
Author:
Bonnekoh HannaORCID,
Kiefer Lea,
Buttgereit Thomas,
Kolkhir Pavel,
Lütke-Eversloh Marie,
Scheffel Jörg,
Maurer Marcus,
Metz MartinORCID
Subject
Immunology and Allergy
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献